Use eConsult services in Epic to support patients with substance use issues

Jun. 2024Important Notices

Providers can now use the two addiction medicine eConsult services in Epic for support when patients present with substance use issues. The eConsults allow providers to communicate with general internal medicine and ob-gyn physician groups specializing in addiction to get recommendations.

To initiate a consultation in Epic for patients with a condition related to substance use, select from the following options:

  • “Electronic Consult/Referral to Alcohol and Drug Treatment”
  • “Addiction Medicine” or “Perinatal Addiction Medicine” for individuals who identify as female and who may have obstetrical or other reproductive health needs

Patients must give verbal, documented consent for this service and are not to be present during the consultation. The eConsult addiction medicine recommendations are documented in the electronic health record and are billable for requesting and responding providers.*

*Depending on the patient's health care provider, they may be charged cost-sharing depending on the terms of their plan.

Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates